Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
thiamine + riboflavin + ascorbic acid
- Development stage
- Unknown
- Lead developer
- Beijing Boya United Pharmaceutical Research Institute
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Compound Vitamin (3) Injection (also known as Plevita S Injection) is a fixed-dose combination of three essential water-soluble vitamins: thiamine (vitamin B1), riboflavin (vitamin B2, as riboflavin sodium phosphate), and ascorbic acid (vitamin C). Originally developed by Fuso Pharmaceutical and approved in Japan in 1985, this formulation is indicated for the prevention and treatment of vitamin B1, B2, and C deficiencies. It is particularly used in patients with increased vitamin demands or insufficient dietary intake, such as those with wasting diseases, pregnant or lactating women, or patients undergoing parenteral nutrition. Thiamine, riboflavin, and ascorbic acid serve as vital cofactors and antioxidants in various metabolic pathways, including carbohydrate metabolism, cellular respiration, and collagen synthesis.
- Brand names
- Plevita S
- Other names
- Compound Vitamin (3) InjectionCompound Vitamins (3) InjectionPlevita S InjectionプレビタS注射液复方维生素复方维生素(3)注射液复方维生素（3）注射液
Beyond the preview
Go deeper on thiamine + riboflavin + ascorbic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on thiamine + riboflavin + ascorbic acid.